Skip to content
★ Sign in to follow
MD

Michael D. Popielec

Executive
Chairman & CEO
Total declarations
34
Companies
2
▲ Purchases (21 ops.)
€715k
▼ Sales (1 ops.)
€59k

Latest filing published 21 Dec 2021 for Ultralife CORP, €22k.

Insider track record

Disclosed buys
21
Disclosed sells
1
Signal history

Closed purchases

Market purchases
21
Positive at T+90
43%
Median T+90
-9.4%

Based on 21 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 04 Nov 2016 · 3657 days ago · €1,501
    +51.1%
    Entry US$4.40 · Close at T+365 US$6.65
  • Filed 03 Jun 2013 · 4907 days ago · €30k
    +8.3%
    Entry US$3.63 · Close at T+365 US$3.93
  • Filed 08 Aug 2012 · 5206 days ago · €17k
    +22.3%
    Entry US$3.09 · Close at T+365 US$3.78
  • Filed 24 May 2012 · 5282 days ago · €9,568
    -3.9%
    Entry US$4.10 · Close at T+365 US$3.94
  • Filed 21 May 2012 · 5285 days ago · €19k
    -1.2%
    Entry US$4.05 · Close at T+365 US$4.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Michael D. Popielec: trading record in brief

Filings by Michael D. Popielec span 2 companies, the busiest being Ultralife Corp and Carlisle Companies Inc. In total, 34 filings cover trades dated from 8 February 2006 to 17 December 2021.

In open-market terms, that means 21 purchases worth €715k on one side and 1 sale worth €59k on the other. On balance, insiders were net buyers of €656k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 6 share grants and 6 option exercises.

The median purchase comes to €20k. No cluster: in 4 purchases, no other insider of the company bought within 30 days. Ninety days after publication, 21 purchases show a median change of -9.4%, with the price up in 43% of them. These figures describe past trades and do not predict future prices.

The newest entry dates from 21 December 2021: an option exercise of €22k, in Ultralife Corp. The latest purchase dates back some time: it was published 3,657 days ago, on 4 November 2016. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Michael D. Popielec

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations34 total
  • ◇
    Director, President and CEOExecutivesUltralife Corp
    24,934 USD26SEC
    6,583 shares@ US$3.787635.4% of flowCommon Stock; $.10 par valueSEC:0001437749-21-029015:0
  • ◇
    Director, President and CEOExecutivesUltralife Corp
    47,154 USD28SEC
    12,709 shares@ US$3.710364.6% of flowCommon Stock; $.10 par valueSEC:0001437749-21-019587:0
  • ◇
    Director, President and CEOExecutivesUltralife Corp
    172,933 USD29SEC
    26,929 shares@ US$6.421870.1% of flowCommon Stock; $.10 par valueSEC:0001437749-20-024388:0
  • ▲
    Director, President and CEOExecutivesUltralife Corp
    1,660 USD22SEC
    400 shares@ US$4.150.6% of flowCommon Stock; $.10 par valueSEC:0001437749-16-041146:0
    Canonical exit: 31 Jan 2017 (T+90)
  • ▲
    Director, President and CEOExecutivesUltralife Corp
    7,786 USD22SEC
    1,899 shares@ US$4.102.9% of flowCommon Stock; $.10 par valueSEC:0001437749-16-041146:1
    Canonical exit: 31 Jan 2017 (T+90)
  • ▲
    Director, President and CEOExecutivesUltralife Corp
    15,990 USD27SEC
    3,900 shares@ US$4.105.9% of flowCommon Stock; $.10 par valueSEC:0001437749-16-041146:2
    Canonical exit: 1 Feb 2017 (T+90)
  • ▲
    Director, President and CEOExecutivesUltralife Corp
    15,964 USD29SEC
    3,801 shares@ US$4.205.9% of flowCommon Stock; $.10 par valueSEC:0001437749-16-041146:3
    Canonical exit: 2 Feb 2017 (T+90)
  • ◇
    President and CEOExecutivesUltralife Corp
    0SEC
    39,147 shares0Common Stock, $.10 par valueSEC:0000875657-15-000055:0
  • ◇
    President and CEOExecutivesUltralife Corp
    0SEC
    17,361 shares0Common Stock; $.10 par valueSEC:0000875657-15-000001:0
  • ◇
    President and CEOExecutivesUltralife Corp
    0SEC
    18,780 shares0Common Stock; $.10 par valueSEC:0000875657-14-000001:0
  • ▲
    President and CEOExecutivesUltralife Corp
    38,600 USD0SEC
    10,000 shares@ US$3.86Common Stock; $.10 par valueSEC:0000875657-13-000003:0
    Canonical exit: 28 Aug 2013 (T+90)
  • ▲
    President and CEOExecutivesUltralife Corp
    50,539 USD0SEC
    17,733 shares@ US$2.85Common Stock; $.10 par valueSEC:0000875657-12-000024:0
    Canonical exit: 4 Nov 2012 (T+90)
  • ▲
    President and CEOExecutivesUltralife Corp
    21,074 USD0SEC
    7,267 shares@ US$2.90Common Stock; $.10 par valueSEC:0000875657-12-000024:1
    Canonical exit: 5 Nov 2012 (T+90)
  • ▲
    President and CEOExecutivesUltralife Corp
    11,305 USD0SEC
    2,724 shares@ US$4.15Common Stock; $.10 par valueSEC:0000875657-12-000022:0
    Canonical exit: 20 Aug 2012 (T+90)
  • ▲
    President and CEOExecutivesUltralife Corp
    12,018 USD0SEC
    2,896 shares@ US$4.15Common Stock; $.10 par valueSEC:0000875657-12-000022:1
    Canonical exit: 21 Aug 2012 (T+90)
  • ▲
    President and CEOExecutivesUltralife Corp
    35,640 USD0SEC
    8,800 shares@ US$4.05Common Stock; $.10 par valueSEC:0000875657-12-000021:0
    Canonical exit: 15 Aug 2012 (T+90)
  • ▲
    President and CEOExecutivesUltralife Corp
    19,514 USD0SEC
    4,725 shares@ US$4.13Common Stock; $.10 par valueSEC:0000875657-12-000021:1
    Canonical exit: 16 Aug 2012 (T+90)
  • ▲
    President and CEOExecutivesUltralife Corp
    24,298 USD0SEC
    5,855 shares@ US$4.15Common Stock; $.10 par valueSEC:0000875657-12-000021:2
    Canonical exit: 19 Aug 2012 (T+90)
  • ▲
    President and CEOExecutivesUltralife Corp
    67,890 USD0SEC
    15,500 shares@ US$4.38Common Stock; $.10 par valueSEC:0000875657-12-000014:0
    Canonical exit: 7 Aug 2012 (T+90)
  • ▲
    President and CEOExecutivesUltralife Corp
    42,655 USD0SEC
    9,500 shares@ US$4.49Common Stock; $.10 par valueSEC:0000875657-12-000014:1
    Canonical exit: 8 Aug 2012 (T+90)
  • ▲
    President and CEOExecutivesUltralife Corp
    86,765 USD0SEC
    18,500 shares@ US$4.69Common Stock, $.10 par valueSEC:0000891839-12-000025:0
    Canonical exit: 21 May 2012 (T+90)
  • ▲
    President and CEOExecutivesUltralife Corp
    78,407 USD0SEC
    16,100 shares@ US$4.87Common Stock, $.10 par valueSEC:0000891839-12-000025:1
    Canonical exit: 22 May 2012 (T+90)
  • ▲
    President and CEOExecutivesUltralife Corp
    26,568 USD0SEC
    5,400 shares@ US$4.92Common Stock, $.10 par valueSEC:0000891839-12-000025:2
    Canonical exit: 23 May 2012 (T+90)
  • ▲
    President and CEOExecutivesUltralife Corp
    116,382 USD0SEC
    23,800 shares@ US$4.89Common Stock; $.10 par valueSEC:0000875657-11-000028:0
    Canonical exit: 16 Nov 2011 (T+90)
  • ▲
    President and CEOExecutivesUltralife Corp
    28,830 USD0SEC
    6,200 shares@ US$4.65Common Stock; $.10 par valueSEC:0000891839-11-000089:0
    Canonical exit: 9 Nov 2011 (T+90)

25 of 34 declarations